| Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5745 | 2021 |
| Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ... The Lancet 396 (10249), 467-478, 2020 | 2956 | 2020 |
| Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ... The Lancet 396 (10267), 1979-1993, 2020 | 1799 | 2020 |
| Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1425 | 2021 |
| T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial KJ Ewer, JR Barrett, S Belij-Rammerstorfer, H Sharpe, R Makinson, ... Nature medicine 27 (2), 270-278, 2021 | 642 | 2021 |
| Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses JR Barrett, S Belij-Rammerstorfer, C Dold, KJ Ewer, PM Folegatti, ... Nature medicine 27 (2), 279-288, 2021 | 363 | 2021 |
| Dynamic m6A methylation facilitates mRNA triaging to stress granules M Anders, I Chelysheva, I Goebel, T Trenkner, J Zhou, Y Mao, S Verzini, ... Life science alliance 1 (4), 2018 | 172 | 2018 |
| The RNA‐binding protein Hfq is important for ribosome biogenesis and affects translation fidelity JM Andrade, RF Dos Santos, I Chelysheva, Z Ignatova, CM Arraiano The EMBO journal 37 (11), e97631, 2018 | 96 | 2018 |
| Human leukocyte antigen alleles associate with COVID-19 vaccine immunogenicity and risk of breakthrough infection AJ Mentzer, D O’connor, S Bibi, I Chelysheva, EA Clutterbuck, T Demissie, ... Nature medicine 29 (1), 147-157, 2023 | 74 | 2023 |
| Absolute quantification of translational regulation and burden using combined sequencing approaches TE Gorochowski, I Chelysheva, M Eriksen, P Nair, S Pedersen, Z Ignatova Molecular Systems Biology 15 (5), e8719, 2019 | 72 | 2019 |
| Genome-wide effects of the antimicrobial peptide apidaecin on translation termination in bacteria K Mangano, T Florin, X Shao, D Klepacki, I Chelysheva, Z Ignatova, ... Elife 9, e62655, 2020 | 35 | 2020 |
| RNA2HLA: HLA-based quality control of RNA-seq datasets I Chelysheva, AJ Pollard, D O’Connor Briefings in Bioinformatics 22 (5), bbab055, 2021 | 11 | 2021 |
| Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease RE Drury, S Camara, I Chelysheva, S Bibi, K Sanders, S Felle, K Emary, ... Nature Communications 15 (1), 3402, 2024 | 9 | 2024 |
| Small vault RNA1-2 modulates expression of cell membrane proteins through nascent RNA silencing A Alagia, J Tereňová, RF Ketley, A Di Fazio, I Chelysheva, M Gullerova Life science alliance 6 (6), 2023 | 8 | 2023 |
| Competition for amino acid flux among translation, growth and detoxification in bacteria I Ferro, I Chelysheva, Z Ignatova RNA biology 15 (8), 991-994, 2018 | 8 | 2018 |
| Molecular correlates of vaccine-induced protection against typhoid fever H Zhu, I Chelysheva, DL Cross, L Blackwell, C Jin, MM Gibani, E Jones, ... The Journal of clinical investigation 133 (16), 2023 | 7 | 2023 |
| A Genome-Wide Association Study of Respiratory Syncytial Virus Infection Severity in Infants M Johnson, I Chelysheva, D Öner, J McGinley, GL Lin, D O’Connor, ... The Journal of Infectious Diseases 229 (Supplement_1), S112-S119, 2024 | 3 | 2024 |
| Genome-wide effects of the antimicrobial peptide apidaecin on translation termination K Mangano, T Florin, X Shao, D Klepacki, I Chelysheva, Z Ignatova, ... bioRxiv, 2020.05. 17.100735, 2020 | 2 | 2020 |
| Spotlight on systems vaccinology: a novel approach to elucidate correlates of protection H Zhu, I Chelysheva, AJ Pollard, D O’Connor Genes & Immunity 25 (4), 336-337, 2024 | 1 | 2024 |
| Genome-wide effects of the antimicrobial peptide apidaecin on translation termination K Mangano, T Florin, X Shao, D Klepacki, I Chelysheva, Z Ignatova, ... bioRxiv, 0 | 1 | |